T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BWLD
1226
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $13.9M | ﹤0.01% |
77,246
+2,146
| +3% | +$334K |
|
|
CMA
1227
DELISTED
Comerica
CMA
| $13.9M | ﹤0.01% |
296,421
-3,800
| -1% | -$178K |
|
|
VAR
1228
DELISTED
Varian Medical Systems, Inc.
VAR
| $13.8M | ﹤0.01% |
182,324
-3,307
| -2% | -$246K |
|
1229
Prestige Consumer Healthcare
PBH
$2.43B
| $13.8M | ﹤0.01% |
398,200
-5,400
| -1% | -$179K |
|
|
SWY
1230
DELISTED
SAFEWAY INC
SWY
| $13.8M | ﹤0.01% |
392,653
+25,020
| +7% | +$865K |
|
1231
Skywest
SKYW
$4.21B
| $13.8M | ﹤0.01% |
1,037,120
-59,800
| -5% | -$644K |
|
|
PETM
1232
DELISTED
PETSMART INC
PETM
| $13.7M | ﹤0.01% |
168,385
-65,400
| -28% | -$4.84M |
|
|
EXAS
1233
DELISTED
Exact Sciences
EXAS
| $13.7M | ﹤0.01% |
497,600
+80,700
| +19% | +$1.96M |
|
|
SP
1234
DELISTED
SP Plus Corporation
SP
| $13.6M | ﹤0.01% |
537,080
+4,600
| +0.9% | +$99.8K |
|
|
ZINC
1235
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
| $13.5M | ﹤0.01% |
854,700
+838,700
| +5,242% | +$12.9M |
|
|
CATM
1236
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $13.5M | ﹤0.01% |
350,494
-2,300
| -0.7% | -$85.6K |
|
|
NVRO
1237
DELISTED
NEVRO CORP.
NVRO
| $13.5M | ﹤0.01% |
+349,200
| New | +$11M |
|
1238
Sixth Street Specialty
TSLX
$1.82B
| $13.4M | ﹤0.01% |
798,540
-2,800
| -0.3% | -$47.6K |
|
|
PRXL
1239
DELISTED
Parexel International Corp
PRXL
| $13.4M | ﹤0.01% |
241,607
+24,527
| +11% | +$1.41M |
|
|
DXYN
1240
DELISTED
Dixie Group Inc
DXYN
| $13.4M | ﹤0.01% |
1,458,720
| – | – |
|
1241
Goodyear
GT
$1.78B
| $13.3M | ﹤0.01% |
466,396
-12,000
| -3% | -$297K |
|
1242
Pinnacle West Capital
PNW
$12.2B
| $13.2M | ﹤0.01% |
192,780
+24,300
| +14% | +$1.51M |
|
|
TEN
1243
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $13.1M | ﹤0.01% |
231,050
+7,700
| +3% | +$414K |
|
1244
Darden Restaurants
DRI
$25.4B
| $13M | ﹤0.01% |
248,072
+25,394
| +11% | +$1.23M |
|
1245
ICICI Bank
IBN
$106B
| $13M | ﹤0.01% |
1,236,895
-91,713
| -7% | -$936K |
|
|
PNNT
1246
Pennant Park Investment Corp
PNNT
$249M
| $13M | ﹤0.01% |
1,361,200
-24,540
| -2% | -$257K |
|
1247
Huron Consulting
HURN
$2.47B
| $13M | ﹤0.01% |
189,384
-59
| -0% | -$3.94K |
|
1248
Infosys
INFY
$50.3B
| $12.9M | ﹤0.01% |
1,640,168
-413,552
| -20% | -$3.35M |
|
1249
Helmerich & Payne
HP
$4.3B
| $12.8M | ﹤0.01% |
190,166
-290
| -0.2% | -$22.6K |
|
|
FDO
1250
DELISTED
FAMILY DOLLAR STORES
FDO
| $12.8M | ﹤0.01% |
161,789
-4,284
| -3% | -$336K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.